These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21200023)

  • 21. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
    Roth P; Keller A; Hoheisel JD; Codo P; Bauer AS; Backes C; Leidinger P; Meese E; Thiel E; Korfel A; Weller M
    Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis.
    Wei D; Wan Q; Li L; Jin H; Liu Y; Wang Y; Zhang G
    Mol Neurobiol; 2015; 51(3):1452-61. PubMed ID: 25081587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
    Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
    JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
    De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
    Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
    Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
    J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usage of Cerebrospinal Fluid for microRNA Analysis].
    Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P
    Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma.
    Hu Y; Zhang Q; Wu Z; Chen K; Xu X; Ma W; Chen B; Jin L; Guan M
    Discov Oncol; 2023 Nov; 14(1):205. PubMed ID: 37971595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Logistic regression modeling of cytokines for cerebrospinal fluid evaluation in primary central nervous system lymphoma.
    Wang D; Wu Y; Ma J; Xu Z; Tao H; Guan Y; Wang J; Chen K; Chen B; Xie J; Jiang H; Guan M
    Clin Chim Acta; 2024 Aug; 562():119879. PubMed ID: 39029646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
    Zajdel M; Rymkiewicz G; Sromek M; Cieslikowska M; Swoboda P; Kulinczak M; Goryca K; Bystydzienski Z; Blachnio K; Ostrowska B; Borysiuk A; Druzd-Sitek A; Walewski J; Chechlinska M; Siwicki JK
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
    Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.
    Robertus JL; Harms G; Blokzijl T; Booman M; de Jong D; van Imhoff G; Rosati S; Schuuring E; Kluin P; van den Berg A
    Mod Pathol; 2009 Apr; 22(4):547-55. PubMed ID: 19287466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
    Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.